Close Menu

Latest news

2023

•  Imexpharm sets a record for revenue and profit growth, confirming its leadership position in
the industry
•  IMP4 goes into operation and IMP2 successfully renews its EU-GMP compliance status for the
second time; IMP3 renews its status for the third time
•  Imexpharm has 11 registration numbers for 6 products in Europe, bringing the total number of
EU MAs to 27 for 11 products
•  Imexpharm becomes the leading domestic pharmaceutical company in the ETC channel
•  The company ranks number one in the Vietnamese antibiotics market, including both foreign
and domestic suppliers

2022

2021

2020

2023

2022

2021

2020

2019

2018

2017

2016